Compounds > 16-fluoroestradiol
Page last updated: 2024-08-24

16-fluoroestradiol and tamoxifen

16-fluoroestradiol has been researched along with tamoxifen in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodack, JW; Katzenellenbogen, JA; Mathias, CJ; VanBrocklin, HF; Welch, MJ1
Jonson, SD; Welch, MJ1
Dehdashti, F; Flanagan, FL; Katzenellenbogen, JA; Mortimer, JE; Siegel, BA; Welch, MJ1
Dunnwald, LK; Ellis, GK; Gralow, JR; Krohn, KA; Linden, HM; Link, JM; Livingston, RB; Mankoff, DA; Peterson, LM; Petra, PH; Schubert, EK; Stekhova, SA1
Fujibayashi, Y; Kobayashi, M; Mori, T; Okazawa, H; Tsuchida, T; Tsujikawa, T; Yoshida, Y1
Ellis, GK; Gralow, JR; Krohn, KA; Kurland, BF; Lawton, TJ; Linden, HM; Link, JM; Livingston, RB; Mankoff, DA; Peterson, LM; Petra, PH; Schubert, EK; Specht, JM1
Adler, S; Bhattacharyya, S; Chen, AP; Choyke, PL; Collins, JM; Do, K; Doroshow, JH; Gonzalez, EM; Jacobs, PM; Kummar, S; Kurdziel, KA; Lin, FI; Lindenberg, ML; Shih, J; Ton, A; Turkbey, B1

Reviews

1 review(s) available for 16-fluoroestradiol and tamoxifen

ArticleYear
PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1998, Volume: 42, Issue:1

    Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Estrogens; Female; Fluorine Radioisotopes; Humans; Ligands; Neoplasm Metastasis; Norprogesterones; Progestins; Radiopharmaceuticals; Rats; Receptors, Estrogen; Receptors, Progesterone; Sex Hormone-Binding Globulin; Structure-Activity Relationship; Tamoxifen; Tomography, Emission-Computed

1998

Trials

1 trial(s) available for 16-fluoroestradiol and tamoxifen

ArticleYear
Utility of
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:3

    Topics: Adult; Aged; Breast Neoplasms; Breast Neoplasms, Male; Estradiol; Estrogen Antagonists; Female; Genital Neoplasms, Female; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Estrogen; Tamoxifen

2017

Other Studies

5 other study(ies) available for 16-fluoroestradiol and tamoxifen

ArticleYear
Titration of the in vivo uptake of 16 alpha-[18F]fluoroestradiol by target tissues in the rat: competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical deve
    Nuclear medicine and biology, 1993, Volume: 20, Issue:6

    Topics: Animals; Binding, Competitive; Dose-Response Relationship, Drug; Estradiol; Female; Fluorine Radioisotopes; Models, Biological; Muscles; Ovary; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tamoxifen; Uterus

1993
Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy.
    European journal of nuclear medicine, 1999, Volume: 26, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Estrogen; Tamoxifen; Time Factors; Tomography, Emission-Computed; Treatment Outcome

1999
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jun-20, Volume: 24, Issue:18

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Estradiol; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Salvage Therapy; Tamoxifen

2006
Distinctive FDG and FES accumulation pattern of two tamoxifen-treated patients with endometrial hyperplasia.
    Annals of nuclear medicine, 2008, Volume: 22, Issue:1

    Topics: Aged; Aged, 80 and over; Endometrial Hyperplasia; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tamoxifen; Tissue Distribution

2008
Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Jul-15, Volume: 17, Issue:14

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Selective Estrogen Receptor Modulators; Tamoxifen; Uterus

2011